Aurora Optoelectronics Co.,Ltd. (SHA:600666)
3.100
+0.220 (7.64%)
Nov 18, 2026, 3:00 PM CST
Aurora Optoelectronics Revenue
Aurora Optoelectronics had revenue of 183.29M CNY in the quarter ending September 30, 2026, with 42.80% growth. This brings the company's total for the last twelve months to 604.05M, up 42.86% year-over-year. In the year 2025, Aurora Optoelectronics had annual revenue of 465.12M with 27.09% growth. That makes Aurora Optoelectronics the 23,473rd largest company in the world by revenue and 4,238th in China.
Revenue (ttm)
604.05M
Revenue Growth
+42.86%
P/S Ratio
10.88
Revenue / Employee
996.78K
Employees
606
Market Cap
7.07B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Aurora Optoelectronics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 465.12M | 99.16M | 27.09% |
| Dec 31, 2024 | 365.97M | 38.06M | 11.61% |
| Dec 31, 2023 | 327.91M | -203.34M | -38.28% |
| Dec 31, 2022 | 531.25M | -168.44M | -24.07% |
| Dec 31, 2021 | 699.69M | 180.14M | 34.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 55.52B |
| Zhejiang Int'l Group | 34.69B |
| Yifan Pharmaceutical | 4.93B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.27B |
| GuangYuYuan Chinese Herbal Medicine | 1.31B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.12B |
| Hangzhou Minsheng Healthcare | 902.62M |
| Chongqing Lummy Pharmaceutical | 720.01M |